Annual CFO
-$28.93 M
+$1.89 M+6.13%
31 December 2022
Summary:
Better Therapeutics annual cash flow from operations is currently -$28.93 million, with the most recent change of +$1.89 million (+6.13%) on 31 December 2022. During the last 3 years, it has fallen by -$23.16 million (-401.04%). BTTX annual CFO is now -401.04% below its all-time high of -$5.77 million, reached on 31 December 2020.BTTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$5.94 M
-$856.00 K-16.83%
30 September 2023
Summary:
Better Therapeutics quarterly cash flow from operations is currently -$5.94 million, with the most recent change of -$856.00 thousand (-16.83%) on 30 September 2023. BTTX quarterly CFO is now -127.09% below its all-time high of -$2.62 million, reached on 31 March 2021.BTTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$26.08 M
+$1.07 M+3.94%
30 September 2023
Summary:
Better Therapeutics TTM cash flow from operations is currently -$26.08 million, with the most recent change of +$1.07 million (+3.94%) on 30 September 2023. BTTX TTM CFO is now -896.68% below its all-time high of -$2.62 million, reached on 31 March 2021.BTTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTTX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -401.0% | +13.5% | -74.3% |
| 5 y5 years | - | - | - |
BTTX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -401.0% | +6.1% | -16.8% | +62.5% | -74.3% | +32.1% |
| 5 y | 5 years | -401.0% | +6.1% | -127.1% | +62.5% | -896.7% | +32.1% |
| alltime | all time | -401.0% | +6.1% | -127.1% | +62.5% | -896.7% | +32.1% |
Better Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$5.94 M(+16.8%) | -$26.08 M(-3.9%) |
| June 2023 | - | -$5.09 M(-41.6%) | -$27.15 M(-5.7%) |
| Mar 2023 | - | -$8.72 M(+37.5%) | -$28.79 M(-0.5%) |
| Dec 2022 | -$28.93 M | -$6.34 M(-9.6%) | -$28.93 M(-24.7%) |
| Sept 2022 | - | -$7.01 M(+4.3%) | -$38.44 M(+0.4%) |
| June 2022 | - | -$6.73 M(-24.0%) | -$38.30 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.86 M(-44.1%) | -$37.06 M(+20.2%) |
| Dec 2021 | -$30.82 M(+433.7%) | -$15.85 M(+130.8%) | -$30.82 M(+105.9%) |
| Sept 2021 | - | -$6.87 M(+25.3%) | -$14.97 M(+84.8%) |
| June 2021 | - | -$5.48 M(+109.5%) | -$8.10 M(+209.5%) |
| Mar 2021 | - | -$2.62 M | -$2.62 M |
| Dec 2020 | -$5.77 M(-7.1%) | - | - |
| Dec 2019 | -$6.22 M | - | - |
FAQ
- What is Better Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Better Therapeutics?
- What is Better Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Better Therapeutics?
- What is Better Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Better Therapeutics?
What is Better Therapeutics annual cash flow from operations?
The current annual CFO of BTTX is -$28.93 M
What is the all time high annual CFO for Better Therapeutics?
Better Therapeutics all-time high annual cash flow from operations is -$5.77 M
What is Better Therapeutics quarterly cash flow from operations?
The current quarterly CFO of BTTX is -$5.94 M
What is the all time high quarterly CFO for Better Therapeutics?
Better Therapeutics all-time high quarterly cash flow from operations is -$2.62 M
What is Better Therapeutics TTM cash flow from operations?
The current TTM CFO of BTTX is -$26.08 M
What is the all time high TTM CFO for Better Therapeutics?
Better Therapeutics all-time high TTM cash flow from operations is -$2.62 M